A detailed history of Cullinan Associates Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Cullinan Associates Inc holds 13,911 shares of EW stock, worth $1.03 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
13,911
Previous 13,911 -0.0%
Holding current value
$1.03 Million
Previous $1.28 Million 28.58%
% of portfolio
0.05%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$72.54 - $95.56 $79,794 - $105,116
1,100 Added 8.59%
13,911 $1.33 Million
Q2 2022

Jul 08, 2022

BUY
$86.5 - $128.27 $544,950 - $808,101
6,300 Added 96.76%
12,811 $1.22 Million
Q2 2021

Jul 07, 2021

BUY
$83.84 - $104.76 $109,914 - $137,340
1,311 Added 25.21%
6,511 $674,000
Q4 2020

Jan 14, 2021

BUY
$71.69 - $91.23 $372,788 - $474,396
5,200 New
5,200 $474,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Cullinan Associates Inc Portfolio

Follow Cullinan Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.